Petrus Trust Company’s AtriCure ATRC Stock Holding History

Petrus Trust Company’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-12,601	Closed	-$413K	–	201
2025 Q2	$413K	Buy	12,601 +5,041	+67%	+$164K	0.04%	186
2025 Q1	$244K	Hold	7,560	–	–	0.02%	472
2024 Q4	$231K	Hold	7,560	–	–	0.02%	512
2024 Q3	$212K	Buy	+7,560	New	+$186K	0.02%	508
2024 Q2	–	Sell	-13,082	Closed	-$398K	–	592
2024 Q1	$398K	Hold	13,082	–	–	0.04%	310
2023 Q4	$467K	Buy	13,082 +1,792	+16%	+$66.6K	0.04%	248
2023 Q3	$495K	Hold	11,290	–	–	0.05%	189
2023 Q2	$557K	Hold	11,290	–	–	0.06%	118
2023 Q1	$468K	Buy	11,290 +5,293	+88%	+$220K	0.06%	116
2022 Q4	$266K	Buy	+5,997	New	+$250K	0.03%	320

Other funds holding ATRC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Petrus Trust Company's ATRC Position: Q3 2025 in Review

Petrus Trust Company sold out of AtriCure (ATRC) in Q3 2025, closing a stake of 12,601 shares — an estimated $413K sold.

Petrus Trust Company first reported a position in ATRC in Q4 2022 and held it in 10 quarters. The position peaked at $557K in Q2 2023. 223 funds tracked by Wall St. Rank hold ATRC as of Q3 2025.

Petrus Trust Company reported no remaining AtriCure position as of Q3 2025 after selling out during the quarter.
Petrus Trust Company sold 12,601 AtriCure shares in Q3 2025, an estimated $413K.
Petrus Trust Company first reported a position in AtriCure in Q4 2022 and held it in 10 quarters.
Petrus Trust Company's AtriCure position peaked at $557K in Q2 2023.
223 funds tracked by Wall St. Rank held AtriCure as of Q3 2025.

Based on Petrus Trust Company's 13F filing for Q3 2025, filed 14 Nov 2025.